T

Timeline

Biotech & Life Sciences · Lausanne, Switzerland · Founded 2007

Timeline is a Swiss consumer health biotech company, with its parent company being Amazentis, focused on developing solutions for healthy aging. The company was founded in 2007 by Chris Rinsch and Patrick Aebischer, who is a medical doctor and neuroscientist. Timeline's foundation is built on over 15 years of research that originated at the École Polytechnique Fédérale de Lausanne (EPFL). The company’s core innovation is Mitopure®, a proprietary and highly pure form of Urolithin A. This ingredient is clinically proven to target mitophagy, a key cellular process for recycling and renewing mitochondria, which are the powerhouses of cells. Optimizing mitochondrial function is essential for maintaining cellular energy, which in turn supports muscle strength, immune resilience, and skin vitality. Timeline's business model is centered on a direct-to-consumer (DTC) approach, primarily through its e-commerce website, timelinenutrition.com, and Amazon. They offer a range of products that incorporate Mitopure®, including nutritional supplements in powder, capsule, and gummy formats, as well as a topical skincare line that includes a serum, barrier cream, and eye cream. The company's strategy involves making its clinically researched products accessible to a broad audience. The company has secured significant strategic investments to fuel its growth, including a CHF 56M (USD 66M) Series D financing round in January 2024. This round was led by BOLD, the venture capital fund of L'Oréal, and included investment from Nestlé, which has been an investor since 2019. These partnerships are crucial for expanding into new product categories and markets across the food, beauty, and health sectors. Timeline holds over 80 patents for its innovations and has conducted more than 25 human clinical trials involving over 2000 participants. Keywords: Urolithin A, Mitopure, cellular nutrition, longevity, healthspan, mitochondrial health, anti-aging, supplements, skincare, biotech, mitophagy, consumer health, Amazentis, cellular energy, muscle strength, immune support, direct-to-consumer, EPFL, Patrick Aebischer, Chris Rinsch